Abstract | OBJECTIVES: Programmed death 1 (PD-1) is an immunoinhibitory receptor and has been identified as a new target for immunotherapy in cancer. Here we report the expression of PD-1 ligand 1 (PD-L1) in surgically resected gastric cancer. MATERIALS AND METHODS: RESULTS: Overexpression of PD-L1 was significantly correlated with tumor invasion (p = 0.011) and associated with poor survival. The number of PD-L1-positive cases increased according to the HER2 score in clinical samples. siRNA-mediated downregulation of HER2 significantly decreased PD-L1 protein expression in MKN45 cells. CONCLUSIONS:
|
Authors | Eiji Oki, Shinji Okano, Hiroshi Saeki, Yuichiro Umemoto, Koji Teraishi, Yu Nakaji, Koji Ando, Yoko Zaitsu, Nami Yamashita, Masahiko Sugiyama, Yuichiro Nakashima, Kippei Ohgaki, Yoshinao Oda, Yoshihiko Maehara |
Journal | Oncology
(Oncology)
Vol. 93
Issue 6
Pg. 387-394
( 2017)
ISSN: 1423-0232 [Electronic] Switzerland |
PMID | 28910818
(Publication Type: Journal Article)
|
Copyright | © 2017 S. Karger AG, Basel. |
Chemical References |
- B7-H1 Antigen
- CD274 protein, human
- PDCD1 protein, human
- Programmed Cell Death 1 Receptor
- ERBB2 protein, human
- Receptor, ErbB-2
- PTEN Phosphohydrolase
|
Topics |
- B7-H1 Antigen
(genetics)
- Carcinoma
(genetics)
- Cell Line, Tumor
- Down-Regulation
(genetics)
- Female
- Gene Expression Regulation, Neoplastic
(genetics)
- Humans
- Immunohistochemistry
(methods)
- Male
- Middle Aged
- PTEN Phosphohydrolase
(genetics)
- Programmed Cell Death 1 Receptor
(genetics)
- Receptor, ErbB-2
(genetics)
- Stomach Neoplasms
(genetics)
|